We have isolated a gene (WS5) that is specifically expressed at the mRNA and protein level in avian fibroblasts transformed by the v-myc oncogene of avian acute leukemia virus MC29. In a conditional cell transformation system, WS5 gene expression was tightly correlated with v-myc activation. The WS5 gene contains 11 exons, encoding a 733-amino acid protein with a transmembrane region and a polycystic kidney disease (PKD) domain. Near the transcriptional start site, the WS5 promoter contains a cluster of four binding sites for the Myc-Max complex and a binding site for transcription factor C/EBPa. Electrophoretic mobility shift assays and chromatin immunoprecipitation showed that Myc, Max and C/EBPa bind specifically to these sites. Functional promoter analyses revealed that both the Myc-binding site cluster and the C/EBPa-binding site are essential for strong transcriptional activation, and that Myc and C/EBPa synergistically activate the WS5 promoter. Ectopic expression of WS5 led to cell transformation documented by anchorage-independent growth. The human melanoma antigen Pmel17, a type I transmembrane glycoprotein, is the mammalian protein with the highest amino acid sequence identity (38%) to WS5. The Pmel17 gene is regulated by the MITF protein, a bHLHZip transcription factor with DNA binding specificities similar to those of Myc/Max. WS5 is also related to human glycoprotein GPNMB expressed in metastatic melanoma cells and implicated in the progression of brain and liver tumors.
Introduction
The myc oncogene was originally identified as a transduced allele (v-myc) representing the oncogenic determinant of avian acute leukemia virus MC29 (Bister and Jansen, 1986) . Deregulation of the cellular c-myc protooncogene by retroviral transduction, chromosomal translocation, promoter insertion, or gene amplification is involved in animal and human tumorigenesis (Nesbit et al., 1999) . The myc gene encodes a bHLHZip protein (Myc) encompassing protein dimerization domains (helix-loop-helix, leucine zipper) and a DNA contact surface (basic region) (Kato and Dang, 1992) . Myc forms heterodimers with the bHLHZip protein Max, binds to specific DNA sequence elements (E-boxes), and is part of a transcription factor network including additional proteins like Mad, Mnt and Mga (Grandori et al., 2000; Eisenman, 2001 ). The dimeric Myc-Max and Max-Mad transcription factors recruit co-activator or corepressor complexes that modify chromatin structure and modulate transcription. They are key regulators of genes critically involved in cellular growth, proliferation, metabolism, differentiation and apoptosis (Dang, 1999; Grandori et al., 2000; Eisenman, 2001; Secombe et al., 2004; Adhikary and Eilers, 2005) .
Although the structures of Myc and Max proteins, their mode of interaction and recognition of DNA have been analysed in detail (Ferre´-D'Amare´et al., 1993; Fieber et al., 2001; Nair and Burley, 2003) , the dissection of the molecular events downstream of the activated Myc transcription factor proved difficult. Myc is involved in many basic cellular functions, and recent studies have suggested that it may regulate, directly or indirectly, up to 15% of all genes (Patel et al., 2004) . For target gene validation, distinction between direct and indirect effects on gene expression is essential. Also, an important unresolved question is whether deregulated oncogenic Myc promotes tumorigenesis by aberrant regulation of its normal targets or by affecting new ones. Several Myc targets have recently been identified that display partial oncogenic potential (Ben-Porath et al., 1999; Zhang et al., 2005; O'Donnell et al., 2006) . Notably, no target gene has been identified so far that can mimic the full oncogenic capacity of myc upon ectopic expression, supporting the notion that the molecular events downstream of myc represent a multifunctional response.
Here, we describe the isolation and complete structural dissection of a direct transcriptional target (WS5) of oncogenic transcription factor Myc. We show that Myc binds directly to the WS5 promoter and activates gene expression in synergy with the C/EBPa transcription factor. Ectopic expression of WS5 in avian fibroblasts leads to anchorage-independent growth, suggesting that deregulation of WS5 contributes to myc-induced oncogenesis. Intriguingly, the WS5 protein product is structurally related to type I transmembrane glycoproteins (Pmel17, GPNMB) highly expressed by human melanoma cells and implicated in the progression of tumors of several organs.
Results

Specific expression of WS5 in myc-transformed avian fibroblasts
We have previously established a conditional cell transformation system using doxycycline-controlled expression of the MC29 v-myc allele. Using this system, several partial cDNA clones isolated by differential screening procedures were recognized as candidate myc target genes (Oberst et al., 1999) . The gene represented by one of these clones (WS5) is characterized here in detail. Northern analysis of RNAs from normal or transformed chicken (CEF) or quail (QEF) embryo fibroblasts using WS5 cDNA as a probe revealed the specific expression of a 2.8-kb mRNA in v-myctransformed cells, but not in normal cells or in cells transformed by v-src, v-jun or by methylcholanthrene ( Figure 1a) . The tight correlation of WS5 mRNA levels with v-myc expression is demonstrated in the conditional cell transformation system (Q/tM ON ) containing a doxycycline-dependent v-myc allele (Oberst et al., 1999) . In a time course experiment, WS5 transcription starts immediately after v-myc activation, v-myc and WS5 mRNA levels then increase in parallel, and both disappear again after v-myc inactivation (Figure 1b ). Specific WS5 activation by v-myc is also detected at the protein level (Figure 1c) . By 30-min pulse labeling, a translational product with an apparent M r of 118 000 (p118 WS5 ) was detected by the WS5-specific anti-peptide serum in cells freshly transformed by the MC29 v-myc gene and in the established v-myc-transformed cell line Q8, but not in normal QEF. The protein is also detectable by in vitro transcription-translation or by WS5 overexpression from a retroviral vector. The minor difference in electrophoretic mobility of p118 WS5 from the different sources is possibly due to differential processing or posttranslational modification. In a chase experiment, p118
WS5 was processed into a protein with an apparent M r of 74 000 (p74
WS5
) that is also found as the major WS5 polypeptide in Q8 cells, and into a protein with an apparent M r of 53 000 (p53 WS5 ). Similar aberrant electrophoretic mobility and extensive processing has been reported for the presumed human homolog of WS5 (see below). None of the proteins recognized by the WS5-specific anti-peptide serum were detected in normal cells or by a control serum (Figure 1c ). The major WS5 polypeptide (p74
) in Q8 cells was also readily detected by an antiserum directed against a hybrid GST-WS5 recombinant protein (not shown).
Structural organization of the WS5 gene and protein A full-length 2355-bp WS5 cDNA clone (accession no. AF077328) was assembled from two overlapping 3 0 cDNA clones obtained by screening of a cDNA library from the MC29-transformed cell line Q8 (Bister et al., 1977) with the original WS5 probe (Oberst et al., 1999) and from three overlapping 5 0 RACE products. To determine the structural organization of the WS5 gene, the nucleotide sequence of a 6017-bp quail genomic DNA segment (accession no. AY496440) hybridizing with a WS5 cDNA probe was determined. The WS5 gene contains 11 exons with the coding region extending through all of them (Figure 2a) . The deduced 733-amino acid WS5 protein has a calculated M r of 74162 (see below). The topography of the WS5 gene locus deduced from the nucleotide sequence of cloned DNA was confirmed by Southern analysis of quail high molecular weight DNA, proving the identity of the gene isolate ( Figure 2b ). Within 120 nucleotides upstream of the transcriptional start site, the WS5 promoter region displays a cluster of four putative Myc-binding sites and an adjacent binding site for transcription factor C/EBPa (Figure 2c ). The cluster of Myc-binding sites contains three canonical (CACGTG or CATGTG) and one noncanonical (CACATG) sequence motives (Blackwell et al., 1993) . The C/EBPa site perfectly conforms to the consensus TTNNNNAA and is detected with a high score by the AliBaba and TFSEARCH algorithms (Grabe, 2002; Matys et al., 2003) . Sequence comparison of the promoter regions of WS5 and of the presumed chicken ortholog Mmp115 (Gallus gallus linkage group E22C19W28 genomic contig, NW_100947.1, nt 3231-2972) revealed conservation of the putative Myc-and C/EBPa-binding sites (Figure 2d ).
An alignment of the deduced amino acid sequences of the WS5 protein and of the human melanoma antigen Pmel17 (Kwon et al., 1991) , the mammalian protein displaying the highest amino acid sequence identity to WS5, is shown in Figure 3 . The overall sequence identity between the human and the quail protein is 38%, whereas the identity between WS5 and the chicken Mmp115 protein (Mochii et al., 1991) is 77% (not shown). The aligned proteins display a signal sequence, a transmembrane region and a central polycystic kidney disease (PKD) domain. The PKD sequence motif was first identified in the large multimodular glycoprotein polycystin-1, the protein product of a gene (PKD1) frequently mutated in cases of autosomal dominant polycystic kidney disease (Bycroft et al., 1999) . The amino acid sequences of WS5 and Pmel17 also contain conserved putative N-glycosylation sites. Similar to the WS5 protein (see above), the 668-amino acid Pmel17 protein (calculated M r 70 992) displays a larger apparent M r of 100 000 and is also processed into smaller polypeptides (Berson et al., 2001 (Berson et al., , 2003 . The sequence similarities, the shared domain topography, and the common biochemical properties reported for Pmel17 and Mmp115 (Theos et al., 2005) suggest that Pmel17 is indeed the human homolog of the closely related avian WS5 and Mmp115 proteins. The WS5 protein also displays 24% sequence identity (not shown) with the WS5, a direct transcriptional target of Myc F Reiter et al human transmembrane glycoprotein GPNMB that is expressed in most metastatic melanoma cells and has been implicated in the progression of several human malignancies (Weterman et al., 1995) .
Specific binding of Myc, Max and C/EBPa to the WS5 promoter
The striking correlation between WS5 expression and v-myc activation (see Figure 1 ) and the presence in the WS5 promoter region of multiple potential Myc binding sites provided circumstantial evidence that Myc directly activates WS5 transcription. This was corroborated by electrophoretic mobility shift analyses (EMSA) showing binding of recombinant protein complexes containing Myc-Max heterodimers (Fieber et al., 2001) to the WS5 promoter region containing the E-box cluster (Figure 4a and b). Interestingly, increasing protein concentration led to the formation of multiple distinct protein-DNA complexes indicating binding to multiple sites in the WS5, a direct transcriptional target of Myc F Reiter et al cluster region. Supershift analysis confirmed the presence in these complexes of the Myc and Max recombinant proteins (Figure 4b ). These results were confirmed and extended by chromatin immunoprecipitation (ChIP) using chromatin from Q8 cells transformed by the MC29 p110 Gag-Myc hybrid protein (Bister et al., 1977) and containing high levels of WS5 mRNA (see Figure 1) . Antisera directed against Myc, Gag or Max revealed binding of p110 gagÀmyc and Max to the WS5 promoter fragment containing the E-box cluster and the adjacent C/EBPa-binding site (Figure 4c ), in agreement with the direct demonstration of p110
gagÀmyc -Max complexes in MC29-transformed cells (Hartl et al., 2003) . Interestingly, antiserum directed against C/EBPa revealed binding of this transcription factor to the WS5 promoter fragment (Figure 4c ), suggesting a functional role for the C/EBPabinding site flanking the E-box cluster (see Figure 2) . Using chromatin from normal QEF for control, only low level binding of Max was detected. Alignment of the deduced amino acid sequences of the quail WS5 protein and the human melanocyte-specific protein Pmel17. In the Pmel17 sequence, amino acid residues are only shown at positions where they differ from the WS5 sequence, and gaps are represented by dashes. A signal sequence, a transmembrane region, and a PKD domain are indicated by yellow, blue, and green shading, respectively. Conserved putative N-glycosylation sites are marked by orange shading.
WS5, a direct transcriptional target of Myc F Reiter et al
Transcriptional activation of the WS5 promoter by Myc and C/EBPa To determine whether Myc-Max and C/EBPa are involved in direct activation of the WS5 promoter, the genomic regions corresponding to nucleotides À238 through þ 38 (pCAT-WS5) or À1260 through þ 38 (pCAT-WS5-L) were tested for their capacity to direct expression of a chloramphenicol acetyltransferase (CAT) reporter gene. Transactivation of the promoter constructs was analysed in normal QEF, in QEF transformed by MC29, or in chemically transformed QT6 cells. The analysis revealed that the WS5 promoter is efficiently activated in myc-transformed cells, but not in QEF or in QT6 cells, and that the short promoter construct is sufficient for full activation (Figure 5a ). CAT analysis of appropriate deletion mutants of pCAT-WS5 revealed that the E-box cluster and the C/ EBPa-binding site are required for efficient WS5 promoter activation (Figure 5b) . Transactivation of the pCAT-WS5 promoter construct was also tested in normal QEF that were transiently co-transfected with pRc/RSV-derived expression vectors encoding v-Myc or C/EBPa transcription factor proteins. Strongest activation was observed when vectors encoding v-Myc and C/ EBPa were transfected simultaneously, and moderate activation was seen when only C/EBPa was introduced (Figure 5c ). To test for equal protein expression in cells transfected with the pRc/RSV-derived expression vectors, transfected cells were labeled with [
35 S]methionine and cell extracts were analysed by immunoprecipitation. The analysis revealed efficient and nearly equimolar expression of p110 gagÀmyc or p44 C/EBPa in these cells (Figure 5d ). The size heterogeneity observed for C/EBPa has been described before and was attributed to the use of alternative initiation codons (Mink et al., 1999) . Northern analysis of normal QEF, of v-myctransformed Q8 cells, or v-jun-transformed VJ cells revealed that the endogenous C/EBPa gene is activated in myc-transformed cells, but that mRNA levels are low or undetectable in normal QEF or in VJ cells (Figure 5e ). In the co-transfection experiments (Figure 5c and d) , ectopic expression of Myc is not sufficient for transactivation since normal QEF do not contain C/EBPa, whereas introduction of C/EBPa leads to moderate activation due to recruitment of endogenous c-Myc and Max proteins. Accordingly, concomitant ectopic expression of v-Myc and C/EBPa and recruitment of endogenous Max leads to strong synergistic activation.
To test for direct interaction between the MC29 GagMyc hybrid protein and C/EBP proteins, co-immunoprecipitation analyses were performed using extracts from MC29-transformed QEF and antisera directed against a C-terminal recombinant v-Myc protein, or against recombinant C/EBPa or C/EBPb proteins. The analyses clearly revealed association of p110 gagÀmyc with C/EBP proteins in MC29-transformed cells (Figure 5f ), confirming and extending previous circumstantial evidence for possible direct interaction between these proteins (Mink et al., 1996; Hartl et al., 2003) .
Overexpressed WS5 induces partial cell transformation The strong and highly specific activation of WS5 in v-myc-transformed cells prompted us to test if overexpression of WS5 by itself would induce any parameters of the transformed phenotype. Hence, the quail WS5 coding sequence was inserted into the replicationcompetent retroviral RCAS vector, and the RCAS-WS5 construct was transfected into QEF and CEF. The empty vector and the RCAS-MC29 vector (Hartl et al., 2003) were used as controls. Ectopic expression of WS5 in cultured cells led to morphological alterations, more pronounced in QEF than in CEF (Figure 6a and c) . Significantly, overexpression of WS5 led to anchorageindependent growth in both cell types, monitored by colony formation in soft agar (Figure 6b and d) . The number of colonies per 1000 cells seeded was 117 (QEF) and 135 (CEF) for the WS5 expressing cells, and 488 (QEF) and 185 (CEF) for the v-myc transformed cells. 32 P-labeled double-stranded oligodeoxynucleotide containing the four E-boxes from the WS5 promoter was used as a probe for EMSA. The probe was incubated with no protein (NP) or with increasing amounts of a mixture of recombinant avian Myc (C-terminal amino acid residues 314-416) and Max (amino acid residues 22-113) proteins. (b) The same probe was incubated with Myc/Max proteins in the absence of serum (no AB) or in the presence of specific antisera directed against the C-terminus of Myc (a-Myc), the N-terminus of Myc (a-Myc-N) or Max (a-Max). The reaction mixtures were analysed by native PAGE (6%, wt/vol). The positions of free DNA and protein-DNA complexes are indicated in the margin. (c) ChIP using chromatin from Q8 cells transformed by the p110 Gag-Myc hybrid protein or from normal QEF. Antisera directed against Myc (C-terminus), Gag, Max or C/EBPa were used for precipitation before PCR amplification of a 273-bp fragment from the WS5 promoter containing the E-box cluster and the C/EBPa-binding site (see Figure 2) . Reactions without antiserum (no AB) or with normal rabbit serum (NRS), or using total chromatin (input) were used as controls. WS5, a direct transcriptional target of Myc F Reiter et al be identified and analysed. This is a considerable challenge since key transcriptional regulators like Myc, involved in the control of many fundamental biological processes, affect the expression of many genes (Neiman et al., 2001; Menssen and Hermeking, 2002; Patel et al., 2004) . However, not all of these genes are necessarily effectors of the biological functions of Myc (Grandori et al., 2000; Eisenman, 2001) . The major task is to distinguish direct target genes of Myc from indirect effects on gene expression. For validation of a direct target, binding of Myc in vivo and tight correlation of transcriptional alterations with Myc expression is required (Eisenman, 2001) . Several direct Myc targets have been well defined (Dang, 1999; Grandori et al., 2000; Hermeking et al., 2000; Eisenman, 2001; Patel et al., 2004) , most of them with biological functions in cell cycle control, metabolism or ribosome biogenesis, but only a few have so far been directly linked to the transforming function of Myc (Eisenman, 2001 , Patel et al., 2004 . These include the ornithine decarboxylase gene (ODC), the tumor-associated membrane glycoprotein gene Tmp, the metastasis-associated protein 1 (MTA1) gene, or the transferrin receptor 1 (TFRC1) gene, that were shown to have oncogenic potential (BenPorath et al., 1999; Eisenman, 2001; Zhang et al., 2005; O'Donnell et al., 2006) . However, none of these genes can fully substitute for myc function. The WS5 gene characterized here meets the stringent criteria of a direct Myc target. Expression of WS5 is tightly correlated with Myc levels, the promoter region contains a cluster of Myc-binding sites that are occupied in vivo by Myc and Max, and transactivation analyses of the wild-type and mutant versions of the promoter directly proved functionality of these sites. Clustering of multiple E-boxes increases the chances of recruiting multiple Myc-Max complexes to a gene, leading to synergistic activation (Hermeking et al., 2000; Levens, 2003) . This is directly supported by our data (see Figure 4) . Interestingly, the WS5 promoter also requires binding of C/EBPa for full activation, indicating that Myc-Max and C/EBPa function synergistically (see Figure 5 ). Furthermore, co-immunoprecipitation revealed direct association of Myc and C/EBP proteins in MC29-transformed cells. C/EBPa is a multifunctional transcription factor that is involved in the specification of the differentiated phenotype through gene activation, but was recently also implicated in the acceleration of cell proliferation and activation of metastasis related genes (Heckman et al., 2003; Liu et al., 2004; Wang and Timchenko, 2005) . Notably, functional interactions of Myc with the C/EBPb protein have been reported previously (Mink et al., 1996; Hartl et al., 2003) .
WS5, a direct transcriptional target of Myc
The protein product specified by the WS5 gene displays the structural hallmarks of a transmembrane glycoprotein. In the extracellular segment, the WS5 protein contains a PKD domain, a protein module with a b-sandwich topology similar to the immunoglobulinlike fold, but defining a distinct PKD protein superfamily (Bycroft et al., 1999) . It has been suggested that PKD domains of cell-surface proteins are involved in ligand-binding or cell-cell interactions (Bycroft et al., 1999 , Jing et al., 2002 . The amino acid sequence of quail WS5 shows the highest degree of identity (77%) with its presumed chicken homolog, the melanocytespecific glycoprotein Mmp115 (Mochii et al., 1991) . The mammalian protein displaying the highest degree of sequence identity (38%) to WS5 is encoded by the human Pmel17 (or SILV) gene (Kwon et al., 1991) . Although the melanocyte-specific type I transmembrane glycoprotein Pmel17 is known to have a central role in pigmentation, its precise function remains controversial (Theos et al., 2005) . Pmel17 function is linked to melanosome biogenesis (Berson et al., 2003) , and it was recently suggested that this gene has a critical role in normal mammalian development, with mutations leading to disease phenotypes (Clark et al., 2006) . Furthermore, Pmel17 is overexpressed in human malignant melanoma at all stages of tumor progression, representing one of the most important melanoma antigens (Theos et al., 2005) . The Pmel17 gene is normally regulated by the melanocyte-specific bHLHZip microphthalmia-associated transcription factor (MITF) that has DNA-binding specificities similar to those of MycMax (Du et al., 2003) . The WS5 protein also shows sequence identity (24%) to another human type I transmembrane glycoprotein, GPNMB (or osteoactivin) (Weterman et al., 1995) , that is overexpressed in most metastatic melanoma cells, but also in cancers of the brain, breast, liver, stomach and pancreas. Furthermore, GPNMB was directly shown to be involved in tumor cell invasion and metastasis (Rich et al., 2003) . Intriguingly, the presumed avian homolog of GPNMB, melanosomal glycoprotein QNR-71 displaying 25% sequence identity to WS5, had been isolated as a gene overexpressed in v-myc-transformed quail neuroretina cells (Turque et al., 1996) . The identification and complete dissection of WS5 as a direct transcriptional target of Myc displaying intrinsic oncogenic potential provides a link between the oncogenic properties of this transcription factor and a new type of target encoding a transmembrane protein.
Materials and methods
Cells and retroviruses
Cell culture and transformation of CEF or QEF was carrired out as described (Bister et al., 1977; Oberst et al., 1999; Bister, 1995, 1998; Bader et al., 2000; Hartl et al., 2001) . The following established lines of transformed QEF (Bister et al., 1977; Hartl et al., 2003) were used: VJ, transformed by ASV17 v-jun; Q8, transformed by MC29 v-myc; R(-)3, transformed by RSV v-src; and QT6, derived from a methylcholanthrene-induced fibrosarcoma. The quail cell lines Q/tM ON and Q/d3 conditionally transformed by doxycyclinedependent v-myc or v-jun alleles, and the retroviral construct RCAS-MC29 have been described (Oberst et al., 1999; Bader et al., 2000; Hartl et al., 2003) . For construction of RCAS-WS5, a cDNA fragment containing the entire WS5 coding region was ligated into the ClaI site of the RCAS-BP vector. DNA transfection and colony assays of transfected cells in 0.3%(w/v) agarose were done as described (Bister et al., 1977; Oberst et al., 1999; Hartl et al., 2001 ).
WS5, a direct transcriptional target of Myc F Reiter et al DNA cloning and nucleic acid analysis cDNA and genomic DNA library construction, subtractive hybridization, DNA labeling, subcloning, Northern and Southern analyses, and nucleotide sequence analysis were performed as described Bister, 1995, 1998; Hartl et al., 2001 Hartl et al., , 2003 . Screening of a Q8-specific cDNA library with the 919-bp insert of a clone isolated from a Q8-QEF subtractive cDNA library and encompassing the 3 0 -end of WS5 cDNA (Oberst et al., 1999) led to the isolation of a 1398-bp 3 0 cDNA clone. The full-length 2355-bp WS5 cDNA was assembled from three overlapping 5 0 -RACE products and from the two cDNA clones described above. WS5 genomic clones were isolated from a quail genomic DNA library as described (Hartl and Bister, 1998) . Hybridization probes for Northern or Southern analyses (Hartl et al., 2003) included cDNA fragments of quail WS5, of chicken c-myc/MC29 v-myc, of chicken C/EBPa (provided by K-H Klempnauer), and of quail glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Protein analysis
In vitro transcription/translation reactions were done as described (Hartl et al., 2001) . To construct pBS-WS5, the ClaI fragment of pA-WS5 containing the WS5 coding region was inserted into the ClaI site of pBluescript II SK( þ ) (Stratagene Inc., Amsterdam, Netherlands). A 13mer peptide (NH 2 -SGESSPLLRANAV-COOH) corresponding to the C-terminal residues of the WS5 protein was used to generate a rabbit polyclonal WS5-specific antiserum. Immunoprecipitations of [
35 S]methionine-labeled proteins from cell lysates or from in vitro transcription/translation reactions, and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were performed as described (Hartl et al., 2001 (Hartl et al., , 2003 . Co-immunoprecipitation of Myc-C/EBP protein complexes from lysates of [
35 S]methionine-labeled cells using antisera directed against a C-terminal recombinant v-Myc protein (see below), or against recombinant C/EBPa or C/ EBPb proteins (provided by K-H Klempnauer; Mink et al., 1999) was as described (Hartl et al., 2003) .
Protein-DNA interaction analysis EMSA was carried out as described (Hartl and Bister, 1998) . A 32 P-labeled 56-bp double-stranded oligodeoxynucleotide corresponding to nucleotide positions À121 to À66 in the WS5 promoter including the four E-boxes was used. A recombinant v-Myc protein (corresponding to the C-terminal residues 314-416 of chicken c-Myc), and a recombinant chicken Max protein (residues 22-113) were prepared as described (Fieber et al., 2001) . For supershift analysis, the following antisera were used: a-Myc, directed against the C-terminal Myc recombinant protein; a-Max, directed against the chicken Max recombinant protein; and a-Myc-N, directed against a recombinant v-Myc protein (corresponding to the N-terminal residues 1-140 of chicken c-Myc).
ChIP was carried out as described (Hartl et al., 2006) . The antisera a-Myc and a-Max (see above), a-Gag directed against avian retroviral Gag proteins (Hartl et al., 2001) , and a-C/EBPa (Mink et al., 1999) were used. PCR was carried out with the primer pair 5 0 -CCGCAGCACCATCGCTGTGC-3 0 (nt positions À238 through À219 in the WS5 promoter) and 5 0 -GTGCTCCGACTCCGGGAGAGG-3 0 ( þ 35 through þ 15) flanking the Myc-and C/EBPa-binding sites.
Transactivation analysis
For construction of the CAT reporter plasmids pCAT-WS5 and pCAT-WS5-L, DNA fragments from the WS5 promoter region with sizes of 276 and 1298 bp corresponding to nucleotides 1124-1399 and 102-1399 in the 6017-bp genomic WS5 sequence (accession no. AY496440) were amplified by PCR and inserted into the HindIII/XbaI sites of the pCATBasic vector (Promega Inc., Mannheim, Germany). For construction of pCAT-WS5DMYC, a 38-bp fragment encompassing the four Myc-binding sites (nucleotides 1250-1287) was deleted from pCAT-WS5 by PCR mutagenesis using internal primers with complementary 5 0 -regions. Site-directed mutagenesis to delete the C/EBPa-binding site was performed as described (Hartl et al., 2001 (Hartl et al., , 2003 ) using pCAT-WS5 or pCAT-WS5DMYC as templates and mutator oligodeoxynucleotides yielding pCAT-WS5DC/EBPa and pCAT-WS5DMYCDC/EBPa, respectively. The pRc/RSV (Invitrogen Inc., Karlsruhe, Germany)-derived eukaryotic expression vector pRc-v-Myc containing the coding region of v-myc has been described (Hartl et al., 2003) . To generate the expression vector pRc-C/EBPa, a 1419-bp EcoRI-XbaI fragment encompassing the coding region of the chicken C/EBPa gene was excised from the plasmid pcDNA3-chC/EBPa (Mink et al., 1999) and ligated into HindIII/XbaI-digested pRc/RSV. DNA transfer into cells by the calcium phosphate method, CATanalysis, and quantification of radioactive signals were done as described (Hartl et al., 2001 (Hartl et al., , 2003 (Hartl et al., , 2006 . DNA transfer into cells by the nucleofection technology (Amaxa Biosystems Inc., Cologne, Germany) was performed as described (Hartl et al., 2001 (Hartl et al., , 2003 . For nucleofections, liposome solution V was applied in combination with the electroporation programs T20 for gene transfer into transformed QEF (Q/MC29, QT6), or program A23 for transfer into normal QEF.
